GLOBUS MEDICAL INC - A (GMED) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:GMED - US3795772082 - Common Stock
GMED Key Statistics, Chart & Performance
The current stock price of GMED is 92.52 USD. In the past month the price increased by 4.22%. In the past year, price decreased by -0.34%.
GMED Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to GMED. When comparing the yearly performance of all stocks, GMED is one of the better performing stocks in the market, outperforming 85% of all stocks.
GMED Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to GMED. GMED scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
GMED Financial Highlights
Over the last trailing twelve months GMED reported a non-GAAP Earnings per Share(EPS) of 3.56. The EPS increased by 22.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.3% | ||
| ROA | 8.32% | ||
| ROE | 9.63% | ||
| Debt/Equity | 0 |
GMED Forecast & Estimates
21 analysts have analysed GMED and the average price target is 106 USD. This implies a price increase of 14.56% is expected in the next year compared to the current price of 92.52.
For the next year, analysts expect an EPS growth of 24.69% and a revenue growth 16.21% for GMED
GMED Ownership
GMED Latest News, Press Relases and Analysis
About GMED
Company Profile
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,300 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Company Info
GLOBUS MEDICAL INC - A
2560 General Armistead Ave
Audubon PENNSYLVANIA 19403 US
CEO: David M. Demski
Employees: 5300
Phone: 16109301800
GLOBUS MEDICAL INC - A / GMED FAQ
What does GLOBUS MEDICAL INC - A do?
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 5,300 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Can you provide the latest stock price for GLOBUS MEDICAL INC - A?
The current stock price of GMED is 92.52 USD. The price decreased by -2.24% in the last trading session.
What is the dividend status of GLOBUS MEDICAL INC - A?
GMED does not pay a dividend.
What is the ChartMill technical and fundamental rating of GMED stock?
GMED has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What do analysts say about GLOBUS MEDICAL INC - A (GMED) stock?
21 analysts have analysed GMED and the average price target is 106 USD. This implies a price increase of 14.56% is expected in the next year compared to the current price of 92.52.
Is GLOBUS MEDICAL INC - A (GMED) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GMED.
How many employees does GLOBUS MEDICAL INC - A have?
GLOBUS MEDICAL INC - A (GMED) currently has 5300 employees.